ETRA insider filings

Electra Therapeutics, Inc. — 11 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2026-11-10. Screen ETRA transaction legs live →

Insider transaction summary — last 90 days

2026-08-23 to 2026-11-21, from the filings listed below: 11 insider filings (Forms 3/4/5). Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By insider — same window

Open-market purchase/sale legs on non-derivative securities, grouped by the filing's reporting owner(s); joint filings appear once. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

InsiderFilingsPurchases (P)Sales (S)Other legs
GORDON CARL L — Director, 10% owner318 legs · 1,898,020 sh · $24,349,642—8
ORBIMED ADVISORS LLC — Director, 10% owner & OrbiMed Capital GP VII LLC — Director, 10% owner & OrbiMed Genesis GP LLC — Director, 10% owner318 legs · 1,898,020 sh · $24,349,642—8
Dong Quehuong (Kathy) — President & CEO, Director1——2
Koe Gary S. — Chief Technical Officer1——2
Parry Graham — Chief Scientific Officer1——2
Stagliano Nancy — Director1——2
Westlake BioPartners Fund I, L.P. — 10% owner & Westlake BioPartners GP I, LLC — 10% owner & Westlake BioPartners Fund II, L.P. — 10% owner & Westlake BioPartners GP II, LLC — 10% owner1———

Recent insider filings — Electra Therapeutics, Inc.

FiledFormInsiderReported transactionsSource
2026-11-104GORDON CARL L — Director, 10% ownerPurchase (P): 9,816 @ $7.85 · Purchase (P): 39,600 @ $7.85 · Purchase (P): 4,000 @ $8.24 · Purchase (P): 16,000 @ $8.24 · Purchase (P): 20,700 @ $8.45 · Purchase (P): 2,000 @ $8.45EDGAR
2026-11-104ORBIMED ADVISORS LLC — Director, 10% owner
OrbiMed Capital GP VII LLC — Director, 10% owner
OrbiMed Genesis GP LLC — Director, 10% owner
Purchase (P): 9,816 @ $7.85 · Purchase (P): 39,600 @ $7.85 · Purchase (P): 4,000 @ $8.24 · Purchase (P): 16,000 @ $8.24 · Purchase (P): 20,700 @ $8.45 · Purchase (P): 2,000 @ $8.45EDGAR
2026-11-054GORDON CARL L — Director, 10% ownerPurchase (P): 24,313 @ $7.84 · Purchase (P): 97,800 @ $7.84 · Purchase (P): 24,400 @ $7.88 · Purchase (P): 98,600 @ $7.88 · Purchase (P): 9,267 @ $7.78 · Purchase (P): 37,100 @ $7.78 · +4 moreEDGAR
2026-11-054ORBIMED ADVISORS LLC — Director, 10% owner
OrbiMed Capital GP VII LLC — Director, 10% owner
OrbiMed Genesis GP LLC — Director, 10% owner
Purchase (P): 24,313 @ $7.84 · Purchase (P): 97,800 @ $7.84 · Purchase (P): 24,400 @ $7.88 · Purchase (P): 98,600 @ $7.88 · Purchase (P): 9,267 @ $7.78 · Purchase (P): 37,100 @ $7.78 · +4 moreEDGAR
2026-09-234GORDON CARL L — Director, 10% ownerConversion (C): 2,002,310 · Conversion (C): 1,087,934 · Conversion (C): 1,703,314 · Purchase (P): 333,333 @ $15 · Conversion (C): 758,279 · Purchase (P): 1,000,000 @ $15 · +4 moreEDGAR
2026-09-234ORBIMED ADVISORS LLC — Director, 10% owner
OrbiMed Capital GP VII LLC — Director, 10% owner
OrbiMed Genesis GP LLC — Director, 10% owner
Conversion (C): 2,002,310 · Conversion (C): 1,087,934 · Conversion (C): 1,703,314 · Purchase (P): 333,333 @ $15 · Conversion (C): 758,279 · Purchase (P): 1,000,000 @ $15 · +4 moreEDGAR
2026-09-213Westlake BioPartners Fund I, L.P. — 10% owner
Westlake BioPartners GP I, LLC — 10% owner
Westlake BioPartners Fund II, L.P. — 10% owner
Westlake BioPartners GP II, LLC — 10% owner
Holdings only — no transactions reportedEDGAR
2026-09-214Koe Gary S. — Chief Technical OfficerConversion (C): 63,656 · Conversion (C): 63,656 (derivative)EDGAR
2026-09-214Stagliano Nancy — DirectorConversion (C): 255,635 · Conversion (C): 255,635 (derivative)EDGAR
2026-09-214Parry Graham — Chief Scientific OfficerConversion (C): 85,504 · Conversion (C): 85,504 (derivative)EDGAR
2026-09-214Dong Quehuong (Kathy) — President & CEO, DirectorConversion (C): 455,484 · Conversion (C): 455,484 (derivative)EDGAR

Recent 8-K events — Electra Therapeutics, Inc.

Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →

FiledFormItems reportedSource
2026-11-128-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2026-09-218-K5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR

Registration filings — Electra Therapeutics, Inc.

Securities Act registration lifecycles tracked for this issuer (live-forward since 2026-08-01), threaded by SEC file number.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?ticker=ETRA returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs